The health tech tracker for the second quarter: the decisive industry deals and events to watch – STAT

0
76

Biotech & Pharma
Health Tech
Business & Policy
Health & Science
Team
Exclusive analysis of biotech, pharma, and the life sciences
Topics
Columns
Tools
Events
Team
Account
More
Follow Us
In-depth analysis of biotech, pharma, and the life sciences
from some of the nation's most trusted and well-connected reporters in the industry
with STAT+ reporters and leading industry experts in our STAT+ Conversations series
hosted by STAT+, plus early-bird access and discounts to industry events around the country
get delivered to your inbox to brief you on the most important industry news of the day
like our CRISPR Trackr and Drug Pricing Policy Tracker
In-depth analysis of biotech, pharma, and the life sciences
from some of the nation's most trusted and well-connected reporters in the industry
with STAT+ reporters and leading industry experts in our STAT+ Conversations series
hosted by STAT+, plus early-bird access and discounts to industry events around the country
get delivered to your inbox to brief you on the most important industry news of the day
like our CRISPR Trackr and Drug Pricing Policy Tracker
By Casey Ross and Katie Palmer April 1, 2022
As another Covid winter turns to spring, we’ll be watching to see whether 2022’s wave of consolidation continues in a digital health industry looking to create more durable businesses coming out of the depths of the pandemic.
Mergers and acquisitions were plentiful in the first three months of the year, with companies combining to introduce new services, broaden revenue streams, and stave off competition from rivals. It seems a safe bet that we’ll see more M&A in the months ahead, as startups and more established players jockey for position in an uneven economy.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
National Technology Correspondent
Casey covers the use of artificial intelligence in medicine and its underlying questions of safety, fairness, and privacy. He is the co-author of the newsletter STAT Health Tech.
Health Tech Correspondent
Katie Palmer is a health tech correspondent at STAT.



This name will appear with your comment
There was an error saving your display name. Please check and try again.
By Lev Facher
By Adam Feuerstein
advertisement
By Adam Feuerstein
By Usha Lee McFarling
By Casey Ross
Reporting from the frontiers of health and medicine

source

LEAVE A REPLY

Please enter your comment!
Please enter your name here